Positions

Selected Publications

Academic Article

Year Title Altmetric
2019 Repeat kidney transplant recipients with active rejection have elevated donor-derived cell-free DNAAmerican Journal of Transplantation.  19:1597-1598. 2019
2018 Organs from deceased donors with false-positive HIV screening tests: An unexpected benefit of the HOPE actAmerican Journal of Transplantation.  18:2579-2586. 2018
2018 Apolipoprotein L1 and Chronic Kidney Disease Risk in Young Potential Living Kidney DonorsAnnals of Surgery.  267:1161-1168. 2018
2018 Kidney transplantation and waitlist mortality rates among candidates registered as willing to accept a hepatitis C infected kidneyTransplant Infectious Disease.  20. 2018
2018 The effect of renal transplantation on left ventricular function, electrocardiography, and mechanical synchrony by gated myocardial perfusion imagingJournal of Nuclear Cardiology2018
2017 Impact of Protease Inhibitor–Based Anti-Retroviral Therapy on Outcomes for HIV+ Kidney Transplant RecipientsAmerican Journal of Transplantation.  17:3114-3122. 2017
2017 Lessons Learned: Early Termination of a Randomized Trial of Calcineurin Inhibitor and Corticosteroid Avoidance Using BelataceptAmerican Journal of Transplantation.  17:2712-2719. 2017
2017 Cell-Free DNA and active rejection in kidney allograftsJournal of the American Society of Nephrology.  28:2221-2232. 2017
2017 Obesity increases the risk of end-stage renal disease among living kidney donorsKidney International.  91:699-703. 2017
2017 Survival benefit of kidney transplantation in HIV-infected patientsAnnals of Surgery.  265:604-608. 2017
2017 Access to kidney transplantation among HIV-infected waitlist candidatesClinical Journal of the American Society of Nephrology.  12:467-475. 2017
2017 Increased Mortality and Graft Loss With Kidney Retransplantation Among Human Immunodeficiency Virus (HIV)–Infected RecipientsAmerican Journal of Transplantation.  17:173-179. 2017
2016 Identification of Optimal Donor–Recipient Combinations Among Human Immunodeficiency Virus (HIV)–Positive Kidney Transplant RecipientsAmerican Journal of Transplantation.  16:2377-2383. 2016
2016 Long-Term outcomes after liver transplantation among human immunodeficiency virus-infected recipientsTransplantation.  100:141-146. 2016
2015 Center-Level Experience and Kidney Transplant Outcomes in HIV-Infected RecipientsAmerican Journal of Transplantation.  15:2096-2104. 2015
2015 A national study of outcomes among HIV-infected kidney transplant recipientsJournal of the American Society of Nephrology.  26:2222-2229. 2015
2014 Immunosuppression regimen and the risk of acute rejection in HIV-infected kidney transplant recipientsTransplantation.  97:446-450. 2014
2014 The prognostic value of left ventricular mechanical dyssynchrony using gated myocardial perfusion imaging in patients with end-stage renal diseaseJournal of Nuclear Cardiology.  21:739-746. 2014
2012 Renal transplantation in HIV patients: A series of four casesIndian Journal of Nephrology.  22:139-142. 2012
2010 QT prolongation is an independent predictor of mortality in end-stage renal diseaseClinical Cardiology.  33:361-366. 2010

Research Overview

  • Outcomes in Kidney transplantation
    HIV and kidney transplantation
    HIV and kidney donation
    Biomarkers in kidney allograft rejection
    Development of biological agents to optimize care in kidney transplant recipients .
  • Investigator On

  • Private Grant  awarded by ASTELLAS PHARMA GLOBAL DEVELOPMENT, INC. - NEW 2018 - 2025
  • Private Grant  awarded by VELOXIS PHARMACEUTICALS A/S 2019 - 2023
  • Private Grant  awarded by CSL BEHRING, LLC 2017 - 2022
  • Private Grant  awarded by MALLINCKRODT, INC. 2017 - 2022
  • Novel Therapies to Modulate the Inflammatory Alloresponse in Renal Grafts  awarded by University of California, San Francisco 2014 - 2021
  • Private Grant  awarded by ASTELLAS PHARMA US, INC. 2017 - 2021
  • Private Grant  awarded by QUARK PHARMACEUTICALS, INC. 2015 - 2020
  • Effects of Inhibiting Early Inflammation in Kidney Transplant Patients - Equipment  awarded by Mount Sinai School of Medicine 2015 - 2020
  • Impact of CCR5 Blockade in HIV + Kidney Transplant Recipients  awarded by University of California, San Francisco 2016 - 2020
  • Private Grant  awarded by TRANSPLANT GENOMICS, INC. 2017 - 2019
  • Comparison of Immune Globulin Intravenous (Human), 10% (IVIG), plus Rituximab vs. IVIG 10% + Placebo (Normal Saline) as Agents to Reduce Donor Specific Antibodies, Improve Transplant Rates and Outcomes in Highly-HLA Sensitized Patients Awaiting Deceased Donor Kidney Transplantation  awarded by Cedars - Sinai Medical Center 2014 - 2019
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION 2015 - 2018
  • Private Grant  awarded by ASTELLAS PHARMA US, INC. 2013 - 2017
  • Using Microarrays to Assess Transplant Biopsies: The Future Standard of Care (INTERCOMEX: The INTERCOM Extension Study)  awarded by University of Alberta at Edmonton 2015 - 2017
  • Private Grant  awarded by ALEXION PHARMACEUTICALS, INC. 2014 - 2017
  • Preserving Renal Function & Protective Immunity via Anti-LFA-1-Based CNI Avoidance  awarded by Emory University 2009 - 2016
  • Private Grant  awarded by ALEXION PHARMACEUTICALS, INC. 2013 - 2016
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2013 - 2016
  • Comparison of Immune Globulin Intravenous (Human), 10% (IVIG), plus Rituximab vs. IVIG 10% + Placebo (Normal Saline) as Agents to Reduce Donor Specific Antibodies, Improve Transplant Rates and Outcomes in Highly-HLA Sensitized Patients Awaiting Deceased Donor Kidney Transplantation  awarded by Cedars - Sinai Medical Center 2014
  • Education And Training

  • Doctor of Medicine, University of Delhi 2004
  • UAB Hospital, Internship 2006
  • Maulana Azad Medical College, Internship 2004
  • UAB Hospital, Residency 2008
  • UAB Hospital, Postdoctoral Fellowship 2010
  • Full Name

  • Shikha Mehta